- Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
Kwangho Kim et al, 2023, Experimental & Molecular Medicine CrossRef - The SMYD family proteins in immunology: An update of their obvious and non-obvious relations with the immune system
Teresa Rubio-Tomás, 2021, Heliyon CrossRef - Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer
Eid Alshammari et al, 2022, World Journal of Gastroenterology CrossRef - Functions of SMYD proteins in biological processes: What do we know? An updated review
Ascensión Rueda-Robles et al, 2021, Archives of Biochemistry and Biophysics CrossRef - SMYD2 aggravates gastrointestinal stromal tumor via upregulation of EZH2 and downregulation of TET1
Yong Ji et al, 2022, Cell Death Discovery CrossRef - Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification
Futaba Inoue et al, 2024, International Journal of Oncology CrossRef - Dissecting the Role of SMYD2 and Its Inhibitor (LLY-507) in the Treatment of Chemically Induced Non-Small Cell Lung Cancer (NSCLC) by Using Fe3O4 Nanoparticles Drug Delivery System
Aasma Munawwar et al, 2023, Pharmaceuticals CrossRef - Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision Medicine
Ryuji Hamamoto et al, 2020, Cancers CrossRef - Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications
Teresa Rubio-Tomás, 2021, Molecular Biology Reports CrossRef - SMYD family in cancer: epigenetic regulation and molecular mechanisms of cancer proliferation, metastasis, and drug resistance
Tae-Su Han et al, 2024, Experimental & Molecular Medicine CrossRef - Recent advances in epigenetic anticancer therapeutics and future perspectives
Liwen Ren et al, 2023, Frontiers in Genetics CrossRef - LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer
Meng Yue et al, 2021, Cancer Cell International CrossRef - Clinical prognostic value of the SMYD2/3 as new epigenetic biomarkers in solid cancer patients: a systematic review and meta-analysis
Mahdieh Razmi et al, 2022, Expert Review of Molecular Diagnostics CrossRef - Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics
An Tong et al, 2023, Frontiers in Genetics CrossRef - Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space
Lama Prema Dhorma et al, 2022, European Journal of Medicinal Chemistry CrossRef - SMYD Protein Family as Promising Biomarkers for Cancer Diagnosis and Prognosis
Yingxue Zhang et al, 2022, Genomic and Epigenomic Biomarkers of Toxicology and Disease CrossRef